- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/14 - Antivirals for RNA viruses
Patent holdings for IPC class A61P 31/14
Total number of patents in this class: 12660
10-year publication summary
|
131
|
236
|
333
|
359
|
1433
|
1675
|
2035
|
1350
|
904
|
213
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2183 |
142 |
| The Regents of the University of California | 20534 |
106 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2968 |
103 |
| Centre National de La Recherche Scientifique | 10865 |
86 |
| Bristol-myers Squibb Company | 4812 |
81 |
| Katholieke Universiteit Leuven | 1253 |
72 |
| Emory University | 1699 |
67 |
| Modernatx, Inc. | 1278 |
67 |
| Janssen Pharmaceuticals, Inc. | 439 |
64 |
| Enanta Pharmaceuticals, Inc. | 432 |
64 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3334 |
57 |
| Vanderbilt University | 1972 |
54 |
| The Trustees of the University of Pennsylvania | 4403 |
53 |
| BioNTech SE | 776 |
53 |
| Board of Regents, The University of Texas System | 6031 |
51 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 858 |
50 |
| Pfizer Inc. | 3366 |
49 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3124 |
47 |
| Institut Pasteur | 789 |
47 |
| The Board of Trustees of the Leland Stanford Junior University | 6594 |
46 |
| Other owners | 11301 |